Skip to content
healthcare.dev

Lisdexamfetamine Dimesylate

NDC 65162-025, Lisdexamfetamine, capsule, from Amneal Pharmaceuticals LLC.

Product NDC
65162-025
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202830
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE40 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
65162-025-096516200250990 CAPSULE in 1 BOTTLE (65162-025-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c11cb3b6-3dff-477b-a249-b4c3118edc5f
  • NADAC price for package 65162002509

    GET /v1/drugs/nadac/65162002509

Use it

Look up 65162-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.